Global laboratory initiative tool for a stepwise process towards tuberculosis laboratory accreditation
Authors
Datema, Tjeerd A. M.Oskam, Linda
Engelberts, Mirjam F. M.
van Beers, Stella M.
Shinnick, Thomas M.
Baker, Martin
Ridderhof, John C.
Scholten, Jerod
van Deun, Armand
Gilpin, Christopher
Klatser, Paul R.
UMass Chan Affiliations
Center for Health Policy and ResearchDocument Type
Letter to the EditorPublication Date
2012-05-01Keywords
*AccreditationClinical Laboratory Techniques
Humans
International Cooperation
Laboratories
Quality of Health Care
Tuberculosis
World Health
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Bacterial Infections and Mycoses
Laboratory and Basic Science Research
Public Health
Respiratory Tract Diseases
Metadata
Show full item recordAbstract
Letter to the Editor about the Global Laboratory Initiative (GLI) tool.Source
Int J Tuberc Lung Dis. 2012 May;16(5):704-5. Link to article on publisher's siteDOI
10.5588/ijtld.11.0701Permanent Link to this Item
http://hdl.handle.net/20.500.14038/34778Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.5588/ijtld.11.0701
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review.Fischer, Shira H.; Tjia, Jennifer; Field, Terry S. (2010-11-01)Medication errors are a major source of morbidity and mortality. Inadequate laboratory monitoring of high-risk medications after initial prescription is a medical error that contributes to preventable adverse drug events. Health information technology (HIT)-based clinical decision support may improve patient safety by improving the laboratory monitoring of high-risk medications, but the effectiveness of such interventions is unclear. Therefore, the authors conducted a systematic review to identify studies that evaluate the independent effect of HIT interventions on improving laboratory monitoring for high-risk medications in the ambulatory setting using a Medline search from January 1, 1980 through January 1, 2009 and a manual review of relevant bibliographies. All anticoagulation monitoring studies were excluded. Eight articles met the inclusion criteria, including six randomized controlled trials and two pre-post intervention studies. Six of the studies were conducted in two large, integrated healthcare delivery systems in the USA. Overall, five of the eight studies reported statistically significant, but small, improvements in laboratory monitoring; only half of the randomized controlled trials reported statistically significant improvements. Studies that found no improvement were more likely to have used analytic strategies that addressed clustering and confounding. Whether HIT improves laboratory monitoring of certain high-risk medications for ambulatory patients remains unclear, and further research is needed to clarify this important question.
-
Monitoring Patient Outcomes After Clinical Laboratory TestingMennemeyer, Stephen T.; Winkelman, James W.; Kiefe, Catarina I. (2000-01-01)Mennemeyer ST, Winkelman JW, Kiefe CI. Monitoring Patient Outcomes After Clinical Laboratory Testing. In MG Bissell, Ed, Laboratory-related Measures of Patient Outcomes: An Introduction, Washington, D.C., AACC Press, Chapter 10, p. 147-160, 2000. Limited preview available via Google Book Search.
-
Randomized ligation control for chromosome conformation captureBelton, Jon-Matthew; Dekker, Job (2015-06-01)In experiments using chromosome conformation capture followed by PCR (3C-PCR) or chromosome conformation capture carbon copy (5C), it is critical to control for intrinsic biases in the restriction fragments of interest and the probes or primers used for detection. Characteristics such as GC%, annealing temperature, efficiency of 3C primers or 5C probes, and length of restriction fragment can cause variations in primer or probe performance and fragment ligation efficiency. Bias can be measured empirically by production of a random control library, as described here, to be used with the 3C library of interest.